Compare RNAC & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNAC | CHPT |
|---|---|---|
| Founded | 2007 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.8M | 204.8M |
| IPO Year | 2016 | N/A |
| Metric | RNAC | CHPT |
|---|---|---|
| Price | $7.47 | $7.05 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 12 |
| Target Price | ★ $38.80 | $12.68 |
| AVG Volume (30 Days) | 191.8K | ★ 544.8K |
| Earning Date | 11-06-2025 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,091,000.00 | ★ $403,793,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.37 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.98 | $6.63 |
| 52 Week High | $20.12 | $22.40 |
| Indicator | RNAC | CHPT |
|---|---|---|
| Relative Strength Index (RSI) | 50.60 | 42.08 |
| Support Level | $7.18 | $6.84 |
| Resistance Level | $8.34 | $7.19 |
| Average True Range (ATR) | 0.56 | 0.31 |
| MACD | 0.06 | 0.07 |
| Stochastic Oscillator | 55.67 | 65.38 |
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.